The earliest developmental origins of dysmorphologies are poorly understood in many congenital 17 diseases. They often remain elusive because the first signs of genetic misregulation may initiate as 18 subtle changes in gene expression, which can be obscured later in development due to secondary 19 phenotypic effects. We here develop a method to trace back the origins of phenotypic abnormalities by 20 accurately quantifying the 3D spatial distribution of gene expression domains in developing organs. By 21 applying geometric morphometrics to 3D gene expression data obtained by Optical Projection 22
Tomography, our approach is sensitive enough to find regulatory abnormalities never previously 23 detected. We identified subtle but significant differences in gene expression of a downstream target of 24 the Fgfr2 mutation associated with Apert syndrome. Challenging previous reports, we demonstrate that 25 Apert syndrome mouse models can further our understanding of limb defects in the human condition. 26
Our method can be applied to other organ systems and models to investigate the etiology of 27 malformations. 28 29 Expanding the potential of OPT from qualitative to quantitative analysis of gene expression patterns is 59 challenging. The expression of genes is characterized by highly dynamic patterns, with fast rates of 60 change over time and fuzzy boundaries that usually do not correspond to well-defined anatomical 61 structures but to tissue regions where cells are dynamically up-and down-regulating genes. The 62 quantification of gene expression patterns has been rarely done [10] [11] [12] [13] [14] [15] [16] . We propose to quantify the shape 63 of developing organs in association with their underlying gene expression patterns applying Geometric 64 Morphometrics (GM), a set of statistical tools for measuring and comparing shapes with increased 65 precision and efficiency [17] [18] [19] [20] [21] [22] . This approach provides the ability to replace qualitative observations with 66 quantification of subtle yet significant biological differences that underlie the processes of 67 morphogenesis altered by disease. 68
Here we illustrate how our method can reveal the genetic origin of developmental defects by 69 investigating limb malformations in Apert syndrome [OMIM 101200]. Apert syndrome is a rare 70 congenital disease, with disease prevalence of 15-16 per million live births, that is characterized by 71 cranial, neural, limb, and visceral malformations 23 . Over 99% of Apert cases are associated with one of 72 two missense mutations, S252W and P253R, on Fibroblast Growth Factor Receptor 2 (FGFR2) 24, 25 . The 73 mutations occur on neighbouring amino acids on the linker region between the second and third 74 extracellular immunoglobulin domains of FGFR2, and alter the ligand-binding specificity of the 75 receptors 26, 27 . Thus, the FGF receptors are activated inappropriately, altering the entire FGF/FGFR 76 signalling pathway and causing dysmorphologies of different organs and systems 28 . Apert syndrome 77 shares craniofacial dysmorphologies with other craniosynostosis syndromes but is differentiated on the 78 basis of limb defects of fore-and hindlimb digits. The craniofacial dysmorphology of Apert syndrome 79 (i.e. premature closure of cranial sutures and patent anterior fontanelle associated with atypical head 80 shape, midfacial retrusion and palatal defects) 23 has been intensively investigated, especially because 81 mouse models show cranial phenotypes that correspond with the human condition [29] [30] [31] [32] [33] . However, the 82 associated limb defects are less well studied, in part because mouse models for Apert syndrome present 83 only subtle limb anomalies [34] [35] [36] , even in those carrying the FGFR2 P253R mutation 34 that is associated 84 with the more severe limb malformations in Apert syndrome 37, 38 . 85
Here we present precise phenotyping of limbs of newborn and embryonic specimens of the Fgfr2 +/P253R 86 Apert syndrome mouse model and reveal significant differences that can be traced to as early as one 87 day after the initiation of limb development. To explore the molecular basis of these initial signs of limb 88 dysmorphology we applied our method combining OPT and GM to assess the expression pattern of a 89 direct target of Fgf signalling, Dusp6, a relevant gene for limb morphogenesis 39, 40 . Our quantitative 90 analyses demonstrate that the Apert syndrome Fgfr2 P253R mutation induces changes in the expression 91 pattern of Dusp6 and that these genetic changes are associated with significant phenotypic alterations. 92
These results provide insight into the origins of limb malformations in Apert syndrome. 93
94

Results
95
Apert syndrome mice present limb malformations at birth. Previous studies reported that Apert 96 syndrome mice do not show obvious abnormalities of the limb 35 , and thus focused their molecular 97 analyses on the skull 34 . Histopathological analyses in Apert syndrome mice only revealed overall limb 98 shortening due to abnormal osteogenic differentiation, but no signs of limb disproportion or 99 syndactyly 34, 36 . As a further test of whether or not the Fgfr2 P253R mutation affects limb development in 100 mice, we first performed an extensive quantitative analysis of the size and shape of individual forelimb 101 bones using data from high resolution microCT images of newborn (P0) mutant and unaffected 102 littermates ( Fig. 1a-f ). Our results revealed many more significant differences between P0 unaffected 103 and Fgfr2 +/P253R mutant littermates than previously reported. We found that the humerus, radius and 104 ulna were statistically significantly shorter in length but had increased bone volumes in Fgfr2 +/P253R 105 mutant mice in comparison to unaffected littermates ( Fig. 1g and Table SI_1 ). More localized size 106 differences were detected in the bones derived from the autopod that give rise to the hands. The distal 107 phalanx of digit I, the proximal phalanx of digit V, and metacarpals II, III and IV were significantly longer 108 in Fgfr2 +/P253R mutant mice ( Fig. 1g and Table SI_1 ). In contrast, the proximal phalanx of digit III was 109 shorter and lower in bone volume in Fgfr2 +/P253R Apert syndrome mice relative to unaffected littermates 110 ( Fig. 1g and Table SI_1 ). The scapula and the clavicle, the bones that form the shoulder girdle, were also 111 significantly affected: the scapula was longer, the clavicle was shorter and both bones showed increased 112 bone volumes in Fgfr2 +/P253R Apert syndrome mice ( Fig. 1g and Table SI_1 ) compared to unaffected 113
littermates. 114
The PCA based on the shape of the humerus did not show marked shape differences between 115 unaffected and Fgfr2 +/P253R Apert syndrome mice ( Fig. 1h ). However, the PCA of the scapula indicated a 116 clear morphological differentiation between groups (Fig. 1i ). The scapula of Fgfr2 +/P253R Apert syndrome 117 mice presented a more robust phenotype, with wider and longer scapulae in comparison to their 118 unaffected littermates. 119
Overall, these size and shape differences demonstrate that Fgfr2 +/P253R Apert syndrome mice present 120 widespread and significant limb dysmorphologies at P0 that were not previously reported and would not 121 have been revealed without quantitative statistical testing. Some defects have a direct correspondence 122 with the human phenotype, such as shoulder anomalies and short humeri 24 . However, in newborn mice 123 we did not detect any clear sign of syndactyly, which is the most prominent limb defect in people with 124 Apert syndrome 41,42 . Since the forelimb of mice is not yet completely ossified at P0 and Fgfr2 +/P253R 125 mutant littermates die shortly after birth, we could not assess whether other limb abnormalities appear 126 later in development. 127 128 A quantitative morphometric method to assess embryonic gene expression patterns. To determine the 129 developmental basis of the limb anomalies quantified in newborn mice, we developed a quantitative 130 method to explore early embryonic limb development. First, to visualize the expression pattern of a 131 downstream target of Fgfr2, we obtained OPT scans of Fgfr2 +/P253R Apert syndrome mouse embryos 132 analysed with WISH to reveal Dusp6 expression ( Fig. 2 ). Qualitative assessment of the 3D 133 reconstructions showed that Dusp6 was widely expressed throughout the embryo from embryonic day 134 (E) 10.5 to E11.5, with highest intensity in the limbs, the head and the spinal cord ( Fig. 2) . Dusp6 was 135 also expressed in the heart with moderate intensity. Visually comparing the distribution of the Dusp6 136 gene expression pattern it was possible to distinguish between embryos at E10.5 and E11.5 stages of 137 development. At E10.5, Dusp6 was prominently expressed in the facial prominences and along the 138 entire spinal cord, whereas at E11.5 the expression of Dusp6 was more widespread in the brain and 139 limited to the tail. Focusing on the limbs, the expression of Dusp6 at the two different stages was also 140 readily distinguishable, with Dusp6 expression domains thinning into a more extended domain along the 141 limb outline as the limb buds grow from E10.5 to E11.5 ( Fig. 2 ). However, due to large amount of 142 developmental variation within litters, Fgfr2 +/P253R mutant and unaffected littermates were not 143 distinguishable from each other (Fig. 2) . 144
Quantitative testing was thus required to more accurately evaluate limb alterations potentially 145 associated with Apert syndrome but undetectable by eye. We developed a method for 3D shape analysis 146 of the limb and associated gene expression pattern of Dusp6 ( Fig. 3 and Video SI_1). This protocol 147 enabled us to determine differences in limb size and shape between genotype groups and whether 148 these phenotypic differences are associated with altered gene expression patterns ( Fig. 3 ). Our 149 approach uses GM methods to directly measure the limb anatomy and gene expression domains 150 segmented from the 3D reconstructions of the embryo OPT scans. As expression of Dusp6 showed a 151 fuzzy spatial gradient, multiple thresholding was used to consistently define a high gene expression 152 pattern ( Fig. 3 , steps from 1 to 5). After manual and semiautomatic recording of 3D coordinates of 153 landmarks on the surfaces of the limb and the gene expression domains blinded to group allocation ( Fig.  154 3, step 6), multivariate statistical analyses were performed to explore shape and size variation and 155 covariation patterns between the limb morphology and the Dusp6 domain ( Fig. 3 , steps 7 and 8). 156
The first signs of limb dysmorphology in Apert syndrome. Since gene expression patterns are highly 157 dynamic and rapidly change in size, shape and position within a few hours of development 15 , individual 158 limb buds from Fgfr2 +/P253R mutant embryos and their unaffected littermates aged between E10.5 and 159 E11.5 were staged using a fine-resolution staging system (http://limbstaging.crg.es) 43 . The staging 160 results showed that the analysed limbs represent a temporal continuum over development, with no 161 significant differences between the staging of unaffected and mutant littermates of the same litter ( Fig.  162 SI_1). We partitioned the time span from E10 to E11.5 into four periods, each one approximately 163 representing 12 hours of development (see Table SI_2 and Methods for further details on sample 164 composition). The analysis of the complete dataset that considers hindlimbs and forelimbs from each 165 litter separately is available as Supplementary Information. 166
We first focused on analysing limb dysmorphology, aiming to determine the youngest stage which 167 showed morphological differences between mutant and unaffected limbs. To trace limb development 168 back in time we first analysed embryos from the oldest period (as the differences would be easier to 169 find) and from there proceeded towards the earlier (younger) periods. In this way we should confidently 170 identify the initiation of limb dysmorphogenesis associated with the Fgfr2 P253R mutation determining 171 using geometric morphometric methods. 172
During the "Late" period, we detected that Fgfr2 +/P253R mice were already clearly separated from their 173 unaffected littermates in the morphospace defined by the Principal Component Analysis (PCA) (Fig. 4a) . 174
Relative to their unaffected littermates, limbs of Fgfr2 +/P253R mice presented subtle phenotypic limb 175 differences: limbs were shorter, wider and more robust, with limited development of the wrist (Fig. 4a ). 176
Quantitative comparison of limb size showed that the limbs of mutant mice were also significantly 177 smaller ( Fig. 5a and Table SI_3 ). Overall, these results confirmed that the Fgfr2 P253R Apert syndrome 178 mutation has an effect on limb development, altering both the size and shape of the limbs. Most likely, 179 these subtle but significant phenotypic differences would have remained undetected by a qualitative 180 approach. Our quantitative approach revealed their statistical significance and pointed to the origin of 181 the Apert syndrome limb malformation prior to E11.5, before the "Late" period. 182
At the "Mid late" period, the limbs of Fgfr2 +/P253R mutant mice were still distinguishable from the limbs 183 of unaffected mice in the morphospace of the PCA (Fig. 4b ). At this period, the limbs of Fgfr2 +/P253R mice 184 lacked the antero-posterior asymmetry and the narrowing of the wrist region more typical of unaffected 185 littermates. Instead, Fgfr2 +/P253R mice showed a limb phenotype that was elongated in the proximo-distal 186 axis and thickened in the dorso-ventral axis (Fig. 4b ), resembling the limb shape of younger unaffected 187 embryos. This shape difference coincided with reduced growth in Fgfr2 +/P253R mice, as the limbs of 188
Fgfr2 +/P253R mice tended to be smaller than unaffected limbs ( Fig. 5a and Table SI_3 ). Therefore, 189 significant differences between unaffected and mutant limbs still could be detected at the "Mid late" 190 period of development and the origins of limb defects associated with Apert syndrome should be sought 191 earlier in development. 192
The first period where no significant differences could be detected between unaffected and Fgfr2 +/P253R 193 Apert syndrome mice was at the "Mid early" period ( Fig. 4c ). Despite internal variation in limb shape, 194
with Fgfr2 +/P253R mice spreading throughout the morphospace and unaffected littermates concentrated 195 on one region, mutant and unaffected littermates completely overlapped. Therefore, limb shape 196 differences could no longer be detected between groups. Limb size differences were not significant 197 either ( Fig. 5a and Table SI_3 ). Therefore, our results suggest that the critical time point of limb 198 dysmorphogenesis associated with Apert syndrome occurred between the "Mid late" and "Mid early" 199 periods, corresponding to the transition period from E10.5 to E11 ( Fig. 4b-c ). 200
Finally, no further sign of limb shape dysmorphology was detected at the "Early" period of development 201 ( Fig. 4d ). At this period there was a great range of developmental variation, with unaffected and 202 Fgfr2 +/P253R mutant mice completely overlapping in the morphospace and all limbs displaying similar 203 incipient bud shapes (Fig. 4d ). The limbs of Fgfr2 +/P253R mice were significantly larger than the limbs of 204 their unaffected littermates ( Fig. 5a and Table SI_3 ), suggesting that at this early time point there is a 205 significant effect of the Fgfr2 P253R mutation on limb size but not on limb shape (Fig. 5a ). 206
Fgfr2 Apert syndrome mutation leads to aberrant overexpression of Dusp6 domains. We decided to 207 obtain direct evidence of altered genetic regulation that could explain the observed limb phenotype by 208 analyzing the shape dynamics of Dusp6 expression, a direct target gene of Fgf signaling. As with limb 209 shape, we first examined the gene expression of Dusp6 in the embryos from the latest period. We found 210 that at the "Late" period, Dusp6 expression was already different between Fgfr2 +/P253R mutant mice and 211 unaffected littermates. The differences were significant both in shape ( Fig. 4e ) and size ( Fig. 5b and 212 Table SI_3 ). In the limbs of unaffected mice, the Dusp6 expression domain appeared as a thin domain 213 underlying the apical ectodermal ridge, whereas in Fgfr2 +/P253R mutant mice the shape of the Dusp6 214 domain was expanded in all directions (Fig. 4e) . Accordingly, the volume of the Dusp6 expression 215 domain was significantly larger in Apert syndrome mice ( Fig. 5b and Table SI_3 ), even when these mice 216 presented significantly smaller limbs (Fig. 5a ). The Dusp6 expression domain thus grew 217 disproportionately in the limbs of Fgfr2 +/P253R mutant mice in the latest period of development ( Fig. 4e) , 218 which is consistent with a reported whole-body size reduction in Fgfr2 +/P253R Apert mice and the over-219 activation of Fgfr2 signaling by the Apert syndrome mutation 27, 44 . 220
At the "Mid late" period, an expanded Dusp6 expression domain persisted on the dorsal and ventral 221 sides of mutant limbs, but was reduced on the anterior and posterior sides (Fig. 4f ). The overall volume 222 of the Dusp6 expression domains remained larger in Fgfr2 +/P253R mutant mice, but the difference was no 223 longer statistically significant ( Fig. 5b and Table SI_3 ). 224
At the "Mid early" period, the separation between unaffected and Fgfr2 +/P253R mutant mice was 225 maintained in the PCA analysis (Fig. 4g) . Unaffected mice showed a Dusp6 expression domain expanded 226 towards the anterior and posterior edges of the expression domain (Fig. 4g) . In contrast, Fgfr2 +/P253R 227 mutant mice did not show the extension and the posterior asymmetry of the Dusp6 expression domain 228 typical of normal limb development, suggesting a lack of differentiation in the Dusp6 expression of 229 mutant limbs (Fig. 4g ). 230 Finally, the "Early" period was the only time point where we did not detect a significant separation 231 between unaffected and Fgfr2 +/P253R mice (Fig. 4h ). The PCA showed variation in the expression domains 232 of Dusp6, with similar gene expression patterns in both shape ( Fig. 4h ) and size ( Fig. 5b and Table SI_3 ) 233 across all mice. Therefore, the first observation of an alteration in the gene expression pattern (Fig. 4g ) 234 occurred earlier than the alteration in the limb shape change (Fig. 4b ). Our analyses provide evidence 235 that differences in the Dusp6 gene expression pattern occurred first, at the "Mid early period", 236 preceding the phenotypic limb differentiation, which occurred a few hours later in development, during Altered Dusp6 expression and limb dysmorphology are highly associated. Finally, we explored the 242 correlation patterns between the limb phenotype and the gene expression pattern to further test 243 whether altered Fgf signaling underlies the limb malformations induced by Apert syndrome Fgfr2 P253R 244 mutation. First, we assessed the relationship between the size of the limbs and the volume of the Dusp6 245 expression domain pooling all the forelimbs and hindlimbs and assessing the correlation between these 246 two traits (Fig. 5c, d) . The trend line showed that for the same limb size, Fgfr2 +/P253R mutant mice showed 247 larger Dusp6 expression domains, both in forelimbs (R 2 =0.4) and hindlimbs (R 2 =0.6). If the extension of 248
the Dusp6 expression only depended on limb growth, a high correlation between the size of the limb 249 and the gene would be expected. However, the moderate correlation found here suggests that the size 250 of the Dusp6 gene expression is not dependent solely on limb size but is also influenced by other factors 251 and could be under further genetic regulatory control. 252
Second, we assessed the morphological integration between the shape of the limbs and the shape of the 253
Dusp6 expression domain. The statistical analysis of the covariance pattern between these shapes can 254 reflect the interaction of the phenotype and the gene expression pattern during limb development. As 255 shown by analysis of additional genes expressed during limb development 15 , even when a gene is 256 expressed within the limb, the shape of the limb and the shape of the gene expression domain are not 257 correlated by definition, and the integration pattern can change from a strong association to no 258 significant correlation within few hours of development 15 . The dynamics of the integration pattern can 259 identify the key periods during which the expression of a gene is relevant for determining the shape of 260 the limb. If the morphological integration is low, the expression of the gene will not be as relevant for 261 the shape of the limb as if the integration is high. If the integration is low, the impact of the altered gene 262 expression on the phenotype will be minimal. If the morphological integration is high, the impact of the 263 genetic mutation will be maximized (i.e., changes of the gene expression pattern will produce changes in 264 the limb shape). Our results showed that the shape of the limb and the shape of the Dusp6 domain were 265 indeed highly correlated (RV=0.88 in forelimbs; RV=0.91 in hindlimbs). This is evidence that altered Fgf 266 signaling induced by the Fgfr2 P253R Apert syndrome mutation will have a direct effect on the limb 267 phenotype. 268
By comparing the morphological integration pattern in mutant and unaffected littermates at different 269 periods, we can test whether this interaction is maintained or disrupted by the disease during 270 development. If the pattern or magnitude of morphological integration was different in mutant mice, it 271 would reveal further mechanisms underlying the etiology of the disease. Our analyses showed that the 272 pattern of morphological integration of the shape of the limbs and the shape of the Dusp6 expression 273 domains was similar in unaffected and Fgfr2 +/P253R mutant mice ( Fig. 5e and Fig SI_6) . Our results 274 confirmed that the Fgfr2 P253R mutation does not disrupt the strong association between limb shape 275 and the Dusp6 expression domain. Therefore, the alteration of the Dusp6 expression pattern caused by 276 the Fgfr2 mutation between E10 and E11.5 will produce the limb dysmorphologies associated with Apert 277 syndrome. Overall, the high correlation between the shapes of the limb and the Dusp6 expression 278 domain provides further evidence that altered Fgf expression due to the Fgfr2 mutation is strongly 279 associated with limb defects in Apert syndrome. syndrome has been done using the same animal models, mainly because previous research reported the 304 absence or subtle malformation of the limbs in the different mouse models for Apert syndrome 34-36 . 305 Contrary to these previous results, our quantitative morphometric analyses demonstrate that the limbs 306 of Fgfr2 +/P253R Apert syndrome mice present with significant defects that are detectable in newborn mice 307 and can be traced back to early embryogenesis (Figs. 1, 4 and 5) . 308
Our analyses provide insight into the genetic origins of these limb defects, showing that altered gene 309 expression patterns in the Fgf signaling pathway precede and contribute to limb dysmorphogenesis in 310
Fgfr2 +/P253R Apert syndrome mice. In fact, we detected that Dusp6 expression patterns were different in 311 unaffected and mutant littermates a few hours before the first limb dysmorphologies appeared (Fig. 4) , 312
and confirmed that limb shape and Dusp6 expression patterns were highly correlated (Fig. 5e ). The 313 altered Fgf signaling observed was due to the Fgfr2 P253R Apert syndrome mutation, which causes loss 314 of ligand specificity of the Fgfr2 isoform and increased affinity of various Fgfs to Fgfr2. Our analyses 315 showed that over-activation of the Fgf signaling pathway results in more expanded (Fig. 4e-g) and larger 316 ( Fig. 5b ) expression domains of Dusp6, a gene that acts as a negative-feedback control of Fgf signaling 49 . 317
A delay in misregulation of the expression of Dusp6 may explain the lack of antero-posterior asymmetry 318 and the shape deficiencies observed in Fgfr2 +/P253R mutant mice (Fig. 4) . We found evidence that limb 319 shape and Dusp6 expression were highly associated ( Fig. 5c-e ), but it is likely that other downstream 320 genes of the Fgf signaling pathway also contribute to the limb shape malformations associated with 321 Apert syndrome. 322
Our analyses also demonstrated that the embryonic limb defects persisted until birth ( Fig. 1) and thus 323 did not disappear over development. For instance, we found that Fgfr2 +/P253R Apert syndrome mice 324 presented postnatal limb malformations involving the shape, length and volume of many bones of the 325 forelimb, including the scapula, humerus, ulna, radius, metacarpals and phalanges ( Fig. 1 and Table  326 SI_1). Though subtle, these malformations suggest that further research into the origins and causes of 327 limb dysmorphologies in Apert syndrome using these and other mouse models is warranted. 328
Our quantitative approach could be similarly applied to investigate other developmental defects and 329 dysmorphologies 50 . OPT and GM can be potentially used to analyze any organ and animal model that 330 can be visualized during development using light microscopy, and any gene whose gene expression 331 pattern can be detected by WISH and show a continuous expression domain over development 15 . We 332 exemplified the method analyzing limb defects in mouse models, but it could be applied to 333 malformations affecting other organs such as the face, the brain, the heart, etc, in mouse models as well 334 as in any other vertebrate animal model, such as zebrafish, chicken and Xenopus. This is relevant as 335 major developmental defects represent a leading cause of infant mortality and affect a small but 336 relevant percentage of the population, severely compromising their quality of life 3 . 337
Through its increased quantitative sensitivity, our method has allowed us to reveal that the mouse 338 model for Apert syndrome does indeed show early defects in limb development. We detected that 339 dysregulation of an Fgf target gene precedes measurable changes in limb bud morphology, thus 340 identifying a relevant component of its genetic etiology. Quantitative evaluation of size and shape 341 should thus be performed before discarding any animal models as useful for investigating human 342 congenital malformations 51 . Our method has the potential to become a high-throughput tool for 343 biomedical research, providing insight into the processes that cause malformations and lead to 344 malfunction, which is essential for understanding diseases and discovering potential therapies. Center for Quantitative Imaging at the Pennsylvania State University (www.cqi.psu.edu) using the HD-358 600 OMNI-X high-resolution X-ray computed tomography system (Varian Medical Systems, Palo Alto, 359 CA). Pixel sizes ranged from 0.01487 to 0.01503 mm, and all slice thicknesses were 0.016 mm. Image 360 data were reconstructed on a 1024×1024 pixel grid as a 16-bit TIFF. To reconstruct forelimb morphology 361 from the μCT images, isosurfaces were produced with median image filter using the software package 362 Avizo 6.3 (Visualization Sciences Group, VSG) ( Fig. 1a-f ). 363
Morphometrics in P0 mice. We assessed forelimb morphology at P0 using unaffected (n=10) and 364 mutant (n=12) littermates of Apert syndrome mouse models. A set of 16 landmarks were collected on 365 each left forelimb, including points on the main bones of the forelimb (phalanges, metacarpals, radius, 366 ulna, humerus, scapula and clavicle), as shown in Fig. 1b-f . To minimize measurement error, each 367 landmark was collected twice by the same observer restricting the deviations between the two trials to 368 0.05 mm. 369
At P0, we estimated the dimensions of the long bones of the forelimbs using the 3D coordinates of the 370 landmarks located at the proximal and distal ends of the bones (Fig. 1b-f ). We also estimated the bone 371 volumes from volume data collected from the μCT scans. To assess size differences in bone length and 372 bone volume between mutant and unaffected P0 mice of the Fgfr2 +/P253R Apert syndrome mouse model, 373
we performed a two-tailed one-way ANOVA on those variables showing a normal distribution, and the 374 non-parametric Mann-Whitney U-Test on those variables that deviated from a normal distribution. The 375 shape of the humerus and the scapula was comparatively assessed in unaffected and E11.5. In total, 32 mouse embryos were harvested and classified by PCR genotyping into unaffected 390 (n=16) and mutant (n=16) littermates (see Fig. SI_1 and Table SI_2 for further details on sample size and 391 composition). Dusp6 gene expression was assessed by Whole-Mount-In-Situ Hybridization (WISH). 392
Mouse embryos were dissected in cold phosphate-buffered saline, 0.1% tween 20 (PBT), fixed overnight 393 in 4% paraformaldehyde (Sigma), dehydrated in a graded PBT/methanol series and stored at -20ºC in 394 methanol. The mouse embryos recovered their original size after rehydration in decreasing series of 395 methanol/PBT. WISH was carried out using Dusp6 antisense RNA probes labelled with digoxigenin-UTP 396 (Roche), following standard protocols 7 . Alkaline phosphatase coupled anti-digoxigenin (anti-DIG-AP, 397
Roche) and NBT/BCIP staining (Roche) were used to reveal the expression pattern for Dusp6. To 398 minimize variations during experimental procedures, all embryos were processed systematically within 399 the same batch, processing unaffected and mutant littermates from different litters in separate tubes, 400 but simultaneously using the same probe, timings and concentration reagents. 401
After embedding in agarose, dehydrating in methanol and chemically clearing the samples with benzyl 402 alcohol and benzyl benzoate (BABB), the stained whole embryos were scanned with both fluorescence 403 and transmission light with a CFP (Cyan Fluorescent Protein) filter using our home-build OPT imaging 404 system mounted on a Leica MZ 16 FA microscope 5 . The embryos were 3D-reconstructed from the 405 resulting 2D images using Matlab and visualized using Amira 6.3 (Visualization Sciences Group, FEI). 406
From the OPT fluorescence scans we produced 3D reconstructions of the embryo surface and we 407 dissected the available right and left fore-and hind limbs of each specimen, resulting in a sample of 101 408 embryonic limbs (Table SI_2 ). From the OPT transmission scans, we recovered the Dusp6 expression 409 domain. As Dusp6 is expressed in a fuzzy spatial gradient, as already shown by other genes 15 , we used 410 3D multiple thresholding to visualize the gene expression domain at different intensities ( Fig. 3 and  411 Video SI_1). To comparatively analyse the gene expression domains across the sample, we inspected for 412 each limb the whole range of threshold values under which the gene expression could be visualized, 413 from the threshold showing its first appearance to the threshold under which it disappeared and was no 414 longer detectable. We analysed the 3D reconstruction based on a threshold computed as 1/3 of the last 415 grey value showing the Dusp6 expression domain, which displayed a Dusp6 domain at high gene 416 expression ( Fig. 3, step 3) . Finally, we obtained 80 limbs (46 forelimbs and 34 hindlimbs) with associated 417 gene expression patterns for Dusp6. 418 Embryo staging. To account for breeding and developmental variation, individual limb buds were staged 419 using our publicly available web-based staging system (http://limbstaging.crg.es) 43 . Considering the 420 spline curve along the outline of the limb, this tool provides a stage estimate with a reproducibility of ± 2 421 hours. According to the staging results, the different mouse litters were ordered following a continuous 422 temporal sequence from E10 to E11.5 (Fig. SI_1 ). To minimize high developmental variation within and 423 among litters of mice, hindlimbs and forelimbs from each litter were analysed separately, except for 424 those from two litters from the earliest stage that were pooled into the same group because their 425 temporal distribution completely overlapped, as shown in Fig. SI_1 . 426
Morphometrics from E10 to E11.5. To capture the size and shape of the limbs and the expression 427 domains of Dusp6, we collected a set of anatomical landmarks as well as curve and surface 428 semilandmarks (Fig. SI_2) , as recommended in structures devoid of homologous landmarks. 429
Semilandmarks are mathematical points located along a curve 54 or a surface 55 within the same object 430 that can be slid to corresponding equally spaced locations across the sample. We used Amira 6.3 431 (Visualization Sciences Group, FEI) to record the anatomical landmarks and Viewbox 4 (dHAL software, 432 Kifissia, Greece) to construct a limb template of surface and curve semilandmarks and to interpolate 433 them onto each target shape (Fig. SI_2) . 434
The 3D landmark coordinates defining the shape of the limb and the Dusp6 expression domain were 435 analysed using Procrustes-based landmark analysis 54 . Semilandmarks were allowed to slide in the GPA 436 by minimizing the bending energy 54-56 . Quantitative shape analyses based on PCA were performed as 437 explained above. 438
We estimated the size of the limb as the centroid size, calculated as the square root of the summed 439 squared distances between each landmark coordinate and the centroid of the limb configuration of 440 landmarks 53 . The volumes of the Dusp6 domains were estimated from the 3D reconstructions of the OPT 441 scans. Size differences in limb size and gene volume between mutant and unaffected embryonic mice 442 were tested for statistical significance using a two-tailed Welch Two Sample t-test. 443
We quantified the integration between the limb and the Dusp6 expression pattern and produced 444 visualizations of the patterns of associated shape changes between them using Two-Block Partial Least 445 Squares analysis (PLS) 57 . This method performs a singular value decomposition of the covariance matrix 446 between the two blocks of shape data (i.e., the limb and the Dusp6 expression domain). 
